Menopause Market Adoption of Digital Health Platforms Accelerates

The global menopause market was valued at USD 17.79 billion in 2024 and is projected to reach USD 24.35 billion by 2030, reflecting a compound annual growth rate (CAGR) of 5.42% between 2025 and 2030. This growth is largely supported by demographic shifts and a rising awareness of health and wellness issues among ageing women.

Key Market Trends & Insights

In 2024, North America held the largest share of the menopause market, accounting for 37.40% of global revenue. Within that region, the U.S. represented a dominant 83.51% of the market. When looking at treatment segments, dietary supplements were the front‐runner, securing 94.23% of market revenue in 2024.

Looking ahead, over 1 billion women worldwide are expected to reach menopause by 2025 — roughly 12% of the global population. Some 75% of women experiencing menopause suffer from vasomotor symptoms (VMS). According to a study from December 2023, around 1.3 million U.S. women aged 51–52 enter menopause each year, about 5% of women aged 40–45 show early menopause symptoms and approximately 1% of women report premature menopause before age 40.

These high incidence rates create a substantial patient base for treatment options such as dietary supplements and over‐the‐counter (OTC) drugs, aimed at relieving symptoms including hot flashes, night sweats, mood swings, vaginal atrophy and osteoporosis. There’s also a significant economic burden: VMS contributes to global healthcare costs of approximately USD 660 million, while productivity loss adds another USD 150 million. Among the conditions that frequently accelerate in menopausal women are hypertension (75%), depression (10%) and osteoporosis (30%).

Symptoms such as hot flashes (affecting around 80% of women in menopause), night sweats, mood changes, and difficulty concentrating are common during the menopausal transition. With a growing ageing female population globally, demand for these products is expected to rise. High prescription drug costs have driven interest in more accessible OTC products, like vaginal gels, moisturizers, and supplements. Telehealth and digital tools are making diagnosis and access to products easier and more affordable, with some OTC drugs priced as low as USD 13 online.

Innovation is gaining traction too: non‐hormonal therapies are being developed. For example, a dual NK-1 and NK-3 receptor antagonist (elinzanetant) is in late‐stage research and a hormone-free NK3 receptor antagonist has launched for menopausal symptom management.

Order a free sample PDF of the Menopause Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

  • 2024 market size: USD 17.79 billion
  • 2030 projected market size: USD 24.35 billion
  • CAGR (2025-2030): 5.42%
  • North America held the largest regional share in 2024
  • Latin America is expected to be the fastest‐growing region

By 2025, more than 1 billion women are expected to have reached menopause globally (≈12% of the global population). The high prevalence of symptoms and large affected patient base will drive market growth. The ageing female population combined with increased health awareness and accessible self-medication options are key growth drivers.

Key Companies & Market Share Insight

Some of the leading players in the menopause market are focusing on expanding product portfolios, forming partnerships and acquiring complementary businesses. Examples include drug trial advancements, geographic expansion and strategic product launches. The market remains moderately competitive due to its fragmentation, and firms are leveraging innovation, digital health and targeted supplements to capture share.

Key Companies List

  • Bayer AG
  • Theramex
  • AbbVie, Inc.
  • Pure Encapsulations, LLC
  • Reddy’s Laboratories Ltd.
  • ReNew Life Holdings Corporation
  • Padagis

Conclusion

In summary, the menopause market is on a steady upward trajectory, reaching nearly USD 24.35 billion by 2030. The dominance of North America, the prevalence of dietary supplements and the large global population of menopausal women underscore this growth. Innovation in non-hormonal therapies and digital health solutions further augments opportunities. As awareness and access continue to improve worldwide, especially in emerging regions, the market appears well-positioned to meet the evolving needs of menopausal women across treatment segments and geographies.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.

Comments

Post a Comment

Popular posts from this blog

Urodynamic Equipment and Consumables Market Forecast: Anticipating Future Innovations

  The global urodynamic equipment and consumables market size is expected to reach USD 449.2 million in 2030 and is projected to grow at a CAGR of 5.7% from 2024 to 2030. This market is anticipated to grow at an unprecedented rate owing to growing geriatric population that exhibits greater vulnerability to urological dysfunctions. In addition, unprecedented upsurge in prevalence of bladder cancer poses high clinical urgency to adopt highly efficient diagnostics, which thereby broadens future growth prospects. In 2017, as per the American Cancer Society, bladder cancer accounted for 5.0% of all cancers in the U.S. The market is also driven by global increase in obesity. As per the Centers for Disease Control and Prevention, approximately 36.0% of adult population is obese. According to a research published in NCBI, obesity has increased the risk of developing various urological conditions, such as prostate cancer, nephrolithiasis, hypogonadism, and urinary tract infections. Furtherm...
Read more

Mobile Device Management Market Thrives with Growth in Cloud-Based Solutions

  According to a recent report by Grand View Research, Inc., the global   mobile device management (MDM) market   is projected to reach USD 28.37 billion by 2030, expanding at a CAGR of 24.5% from 2025 to 2030. This growth is primarily attributed to the increasing use of mobile devices in the workplace and the growing need to manage and secure them effectively. As smartphones, tablets, and other mobile devices become more prevalent, employees are increasingly using their personal devices for work—an approach known as Bring Your Own Device (BYOD). This trend is contributing to the rising number of mobile devices requiring centralized oversight and protection. MDM solutions offer organizations a unified platform to oversee and secure mobile devices, enabling functions such as security policy enforcement, device usage monitoring, and remote data wiping in cases of loss or theft. As companies continue to implement BYOD strategies or issue corporate devices to employees, deman...
Read more

U.S. Interventional Oncology Market Boosted by Aging Population

  The   U.S. interventional oncology market   size was estimated at USD 998.4 million in 2024 and is projected to reach USD 1,597 million by 2030, expanding at a CAGR of 8.17% from 2025 to 2030. This market growth is primarily driven by the increasing prevalence of cancer, continuous technological advancements in minimally invasive treatments, expanding investments in interventional oncology, and the aging population across the U.S. A major contributing factor is the rising incidence of cancer in the country. According to the American Cancer Society, approximately 2,041,910 new cancer cases are expected to be diagnosed in the U.S. in 2025, with 618,120 projected cancer-related deaths. As conventional therapies like chemotherapy and radiation often lead to significant side effects, minimally invasive techniques such as radiofrequency ablation and microwave ablation are becoming more popular. These procedures target tumors precisely while minimizing harm to surrounding tiss...
Read more